This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hesketh, P. J. Search for Related Content PubMed Articles by Hesketh, P. J. Social Bookmarking                            What's this?

Penny Wise, Dollar Foolish Approach to Antiemetic Use May Compromise Patient Care

St Elizabeth's Medical Center, Boston, MA

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

A number of surveys have consistently shown that among the potential adverse effects of cancer treatment, patients rate chemotherapy-induced nausea and vomiting (CINV) as one of the most feared problems.^1,2 Over the past 20 years, substantial progress has been made in developing more effective and better tolerated means to prevent CINV. With appropriate application of evidence-based antiemetic treatment, nausea and vomiting can be completely prevented in the majority of patients with cancer receiving chemotherapy.³

A recent coverage determination by National Government Services (NGS)—a Part A/Part B Medicare Administrative Contractor—threatens to compromise the ability of patients to achieve complete control of . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?